| |
| |
|
| Insider
Information: |
Schmertzler Michael |
| Relationship: |
10% Owner |
| City: |
New York |
| State: |
NY |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
848,271 |
|
|
Indirect Shares
|
6,579,522 |
|
|
| Direct
Value |
$88,674,237 |
|
|
|
Indirect Value
|
$382,779,930 |
|
|
| Total
Shares |
7,427,793 |
|
|
| Total
Value |
$471,454,166 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
1
|
0
|
|
Stock
price went up :
|
1
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
1.0
|
0.0
|
| Percentage
Gain/Loss : |
 103.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Cytokinetics Inc |
CYTK |
Director |
2004-04-29 |
0 |
2010-06-03 |
4,340,923 |
Premium* |
|
|
PTC Therapeutics, Inc. |
PTCT |
|
2024-02-15 |
123,266 |
2019-01-25 |
1,386,594 |
Premium* |
|
|
Hamilton Lane Inc |
HLNE |
10% Owner |
2021-03-04 |
725,005 |
2019-09-12 |
852,005 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
36 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 2 of 2
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2010-06-03 |
4 |
S |
$3.00 |
$16,146 |
I/I |
(5,382) |
4,340,923 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2010-05-06 |
4 |
S |
$3.03 |
$101,341 |
I/I |
(33,446) |
4,953,978 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • – |
2010-05-05 |
4 |
S |
$3.04 |
$1,222,384 |
I/I |
(402,100) |
4,987,424 |
0 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2016-09-23 |
4 |
OE |
$10.85 |
$651,000 |
D/D |
60,000 |
86,766 |
0 |
- |
|
| CYTK |
Cytokinetics Inc |
Director |
– • • |
2004-04-29 |
4 |
OE |
$12.00 |
$37,263,132 |
I/I |
3,105,261 |
3,105,261 |
|
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • • |
2013-06-25 |
4 |
B |
$15.00 |
$7,999,995 |
I/I |
533,333 |
1,297,369 |
2.25 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • • |
2014-02-19 |
4 |
B |
$24.50 |
$563,500 |
I/I |
23,000 |
1,320,369 |
2.25 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2024-01-08 |
4 |
AS |
$27.81 |
$41,715 |
D/D |
(1,500) |
115,266 |
0 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2019-01-25 |
4 |
B |
$30.20 |
$1,999,995 |
I/I |
66,225 |
1,386,594 |
2.1 |
- |
|
| PTCT |
PTC Therapeutics, Inc. |
Director |
– • – |
2020-03-16 |
4 |
B |
$32.48 |
$324,846 |
D/D |
10,000 |
100,066 |
2.39 |
% |
|
| PTCT |
PTC Therapeutics, Inc. |
|
– • – |
2023-06-07 |
4 |
AS |
$44.86 |
$44,860 |
D/D |
(1,000) |
116,766 |
0 |
% |
|
36 Records found
|
|
Page 2 of 2 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
